(Q37809485)

23 August 2017

0 references

The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis (English)

1 reference

23 August 2017

0 references

0 references

0 references

1 reference

botulinum toxin type A

1 reference

7

Lehana Thabane

1 reference

23 August 2017

5

Abi Vijenthira

1 reference

23 August 2017

Tony Zhang

1

1 reference

23 August 2017

Aleem Adatia

2

1 reference

23 August 2017

Wasifa Zarin

3

1 reference

23 August 2017

Misha Moitri

4

1 reference

23 August 2017

Rong Chu

6

1 reference

23 August 2017

Walter Kean

8

1 reference

23 August 2017

publication date

13 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

19

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

21-34

1 reference

https://scigraph.springernature.com/pub.10.1007/s10787-010-0069-x

23 August 2017

exact match

0 references

cites work

Evidence for antinociceptive activity of botulinum toxin type A in pain management

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Focused review: myofascial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

The analgesic effect of botulinum-toxin A on postwhiplash neck pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Use of botulinum toxin in the treatment of chronic myofascial pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Botulinum toxin A and chronic low back pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Botulinum toxin: dosing and dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Treatment of chronic low back pain with botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Focused review: Botulinum toxin type A therapy in chronic pain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Quality of life in chronic musculoskeletal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

A systematic review identifies a lack of standardization in methods for handling missing variance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0069-X

Injection of type A botulinum toxin into extraocular muscles for correction of strabismus.

21 January 2018

1 reference

12 December 2020

Botulinum toxin A for the treatment of chronic neck pain

1 reference

12 December 2020

A double-blind, controlled study of botulinum toxin A in chronic myofascial pain

1 reference

12 December 2020

Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial

1 reference

12 December 2020

A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder

1 reference

12 December 2020

Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study

1 reference

12 December 2020

Botulinum toxin in the treatment of myofascial pain syndrome

1 reference

12 December 2020

One man's poison--clinical applications of botulinum toxin

1 reference

12 December 2020

Attention and somatic awareness in chronic pain

1 reference

12 December 2020

Depression and the experience of chronic back pain: a study of related variables and age differences

1 reference

12 December 2020

Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses

1 reference

12 December 2020

Burden of major musculoskeletal conditions.

1 reference

12 December 2020

10.1007/S10787-010-0069-X

Identifiers

DOI

1 reference

23 August 2017

1 reference